Azuma H, Phillips J D, Green W R
Department of Microbiology, Dartmouth Medical School, Hanover, NH 03756.
J Immunol. 1987 Oct 1;139(7):2464-73.
AKR/Gross leukemia virus-induced tumor reactive cytotoxic T lymphocyte (CTL) clones were derived from C57BL/6 spleen cells. Analysis of their specificity pattern was performed by using a panel of target cells such as E male G2 and AKR.H-2bSL1 (susceptible tumors to polyclonal anti-AKR/Gross virus CTL), and cl. 18-5 and cl. 18-12 (insusceptible variant sublines derived from AKR.H-2bSL1). Several of these CTL clones were selected for further study. Lysis of Gross cell surface antigen-positive tumor cells by these clones was restricted by the H-2Kb molecule. The cell surface phenotype of these clones was Thy-1.2+, Lyt-2.2+, L3T4-, a phenotype consistent with that of polyclonal anti-AKR/Gross CTL, suggesting that they were of conventional CTL origin. According to their fine specificity pattern, the CTL clones were divided into two major groups (A and B) which were further subdivided into five and three subgroups, respectively. The specificity of group A clones was essentially the same as that of the standard polyclonal CTL population except for a variable level of natural killer-like activity by some of the CTL clones. That is, group A clones did not efficiently lyse the insusceptible variant tumors nor any of Friend-Moloney-Rauscher-positive tumors tested, but they showed strong lytic activity to susceptible tumors and iododeoxyuridine-treated insusceptible variants. Thus, their CTL activity appeared to be strictly directed to Gross cell surface antigen-positive tumors that are susceptible to polyclonal anti-AKR/Gross virus CTL. In contrast, group B clones could lyse both susceptible and insusceptible variant tumors and also a Friend virus-induced tumor (FBL3). Therefore, as defined by these CTL clones, at least two distinct antigenic systems (A and B), each with several antigenic determinants, appeared to be present. Because recent findings suggested that most of the polyclonal anti-AKR/Gross virus CTL activity appeared to be directed to N-ecotropic proviral determinants, we further investigated the nature of these two antigenic systems by use of additional target cells including lipopolysaccharide (LPS)-stimulated spleen cell blasts from AKXL recombinant inbred strains and retrovirus-infected fibroblasts. Group A clones could lyse all LPS blasts derived from AKXL recombinant inbred strains containing the AKV-1 proviral genome, but lysed only very insufficiently or did not lyse AKV-1-negative blasts containing the AKV-3 and/or AKV-4 provirus.(ABSTRACT TRUNCATED AT 400 WORDS)
AKR/Gross白血病病毒诱导的肿瘤反应性细胞毒性T淋巴细胞(CTL)克隆源自C57BL/6小鼠的脾细胞。通过使用一组靶细胞,如E雄性G2和AKR.H-2bSL1(对多克隆抗AKR/Gross病毒CTL敏感的肿瘤),以及cl.18-5和cl.18-12(源自AKR.H-2bSL1的不敏感变异亚系),对它们的特异性模式进行了分析。选择了其中几个CTL克隆进行进一步研究。这些克隆对Gross细胞表面抗原阳性肿瘤细胞的裂解受H-2Kb分子限制。这些克隆的细胞表面表型为Thy-1.2+、Lyt-2.2+、L3T4-,这一表型与多克隆抗AKR/Gross CTL一致,表明它们起源于传统的CTL。根据其精细特异性模式,CTL克隆被分为两个主要组(A和B),分别进一步细分为五个和三个亚组。A组克隆的特异性与标准多克隆CTL群体基本相同,只是一些CTL克隆具有可变水平的自然杀伤样活性。也就是说,A组克隆不能有效地裂解不敏感的变异肿瘤或任何测试的Friend-Moloney-Rauscher阳性肿瘤,但它们对敏感肿瘤和碘脱氧尿苷处理的不敏感变异体表现出强烈的裂解活性。因此,它们的CTL活性似乎严格针对对多克隆抗AKR/Gross病毒CTL敏感的Gross细胞表面抗原阳性肿瘤。相比之下,B组克隆可以裂解敏感和不敏感的变异肿瘤以及Friend病毒诱导的肿瘤(FBL3)。因此,根据这些CTL克隆的定义,似乎存在至少两个不同的抗原系统(A和B),每个系统都有几个抗原决定簇。由于最近的研究结果表明,大多数多克隆抗AKR/Gross病毒CTL活性似乎针对N-亲嗜性前病毒决定簇,我们通过使用额外的靶细胞,包括来自AKXL重组近交系的脂多糖(LPS)刺激的脾细胞母细胞和逆转录病毒感染的成纤维细胞,进一步研究了这两个抗原系统的性质。A组克隆可以裂解所有源自含有AKV-1前病毒基因组的AKXL重组近交系的LPS母细胞,但只能非常低效地裂解或不能裂解含有AKV-3和/或AKV-4前病毒的AKV-1阴性母细胞。(摘要截断于400字)